RecruitingNCT05002556

AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

Sponsor

Association Francaise d'Urologie

Enrollment

8,000 participants

Start Date

Feb 21, 2023

Study Type

OBSERVATIONAL

Conditions

Non Muscle Invasive Bladder Cancer

Summary

The AFU has set itself the task of setting up a register of medical practices in order to define possible improvements in the therapeutic management and follow-up of NMIBC. In order to obtain representative data, all urologists who are members of the AFU may be invited to include their patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This French registry study tracks how well urine-based molecular biomarker tests (tests that look for cancer signals in urine) perform in monitoring people with non-muscle-invasive bladder cancer. The goal is to understand whether these tests can replace or reduce the need for invasive procedures like cystoscopies. **You may be eligible if...** - You are 18 or older and are being monitored for non-muscle-invasive bladder cancer - You had a urine molecular test performed before your most recent biopsy or diagnosis of recurrence - You are receiving follow-up care at one of the participating centers in France - You are covered by French social security **You may NOT be eligible if...** - Your bladder tumor is not the urothelial (transitional cell) type - You are unwilling to continue follow-up at the study center - You are legally protected (under guardianship) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(44)

Hopital Prive de Provence

Aix-en-Provence, France

CHU Angers

Angers, France

Hopital Privé Arras les Bonnettes

Arras, France

Centre hospitalier Privé Montgradé

Aubergenville, France

Centre Hospitalier Beauvais Simone Veil

Beauvais, France

CHU Caen

Caen, France

Hôpital Privé de Sévigné

Cesson-Sévigné, France

Clinique des Cèdres

Cornebarrieu, France

GH Eaubonne-Montmorency Hopital Simone Veil

Eaubonne, France

CHD Vendée

La Roche-sur-Yon, France

CHU Kremlin Bicêtre APHP

Le Kremlin-Bicêtre, France

Pôle Santé Sud

Le Mans, France

Clinique Bon Secours

Le Puy-en-Velay, France

Hopital Franco-Britannique Cognac Jay

Levallois-Perret, France

Clinique Mutualiste de la porte de l'Orient

Lorient, France

Clinique de la Sauvegarde

Lyon, France

Hopital Edouard Heriot

Lyon, France

Hopital Lyon Sud

Lyon, France

Clinique de la Région Mantaise

Mantes-la-Jolie, France

Hôpital privé Européen - Marseille

Marseille, France

Centre Hospitalier Martigues

Martigues, France

Grand Hôpital de l'Est-Francilien

Meaux, France

Clinique Beau Soleil

Montpellier, France

CHU Nimes

Nîmes, France

CH Saint-Louis APHP

Paris, France

GH Paris Saint Joseph

Paris, France

Hôpital Européen Georges Pompidou APHP

Paris, France

GH Pitié-Salpêtrière APHP

Paris, France

CH Perpignan

Perpignan, France

GHT Novo - CH René Dubos Pontoise

Pontoise, France

Centre Hospitalier Annecy Genevois

Pringy, France

Clinique la Croix du Sud

Quint-Fonsegrives, France

Clinique Mathilde

Rouen, France

Clinique Saint Hilaire

Rouen, France

Clinique Pasteur

Royan, France

Clinique Saint Germain en laye

Saint-Germain-en-Laye, France

Hopital Privé Saint Grégoire

Saint-Grégoire, France

Clinique Santé Atlantique

Saint-Herblain, France

Clinique de l'Union

Saint-Jean, France

Polyclinique de l'Europe

Saint-Nazaire, France

Centre Hospitalier de Saintonge

Saintes, France

Hopital Foch

Suresnes, France

Polyclinique de l'Ormeau

Tarbes, France

Clinique Pasteur

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05002556

Related Trials

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

NCT057963759 locations

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

NCT0663742313 locations

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

NCT0728383514 locations

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

NCT0720622547 locations

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

NCT0548386817 locations